Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2016-11-03
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uterine Transplantation for the Treatment of Uterine Factor Infertility
NCT02573415
Uterine Allotransplantations Using Uterine Grafts From Brain-dead Female Donors
NCT02637674
The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial
NCT03307356
Human Clinical Trial of Uterine Transplantation in the United Kingdom
NCT02388802
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
NCT01468935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uterus transplantation
uterus transplantation
transplantation of a uterus from a deceased donor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterus transplantation
transplantation of a uterus from a deceased donor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mucosal neovagina of at least 7 cm
* In a stable relationship for at least 1 year
* Child wish
* Good renal function (and presence of both kidneys)
* Psychologically stable and compliant
* At least 8 frozen embryos after IVF/intracytoplasmic sperm injection \[ICSI\]
* Living in Belgium and a good health insurance
* Willing and able to provide informed consent
Exclusion Criteria
* Major chronic illnesses
* Other risk factors or malignancies
* BMI \> 30
18 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghent University Hospital - Women's Clinic
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC/2016/0731
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.